| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.88.3.1083 |
| P698 | PubMed publication ID | 8353870 |
| P2093 | author name string | T Fuchs | |
| H Garan | |||
| J N Ruskin | |||
| D S Cannom | |||
| D M Finkelstein | |||
| E Kelly | |||
| B A McGovern | |||
| D F Torchiana | |||
| G J Vlahakes | |||
| A C Powell | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiac arrest | Q202837 |
| P304 | page(s) | 1083-1092 | |
| P577 | publication date | 1993-09-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest | |
| P478 | volume | 88 |
| Q78503457 | ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Commit |
| Q77299220 | Antiarrhythmic drugs and devices for the management of ventricular tachyarrhythmia in ischemic heart disease |
| Q33544348 | Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart". |
| Q43285794 | Antibiotic prophylaxis in permanent pacemaker implantation |
| Q50919318 | Baseline characteristics of patients in the coronary artery bypass graft (CABG) Patch Trial. |
| Q33535034 | Can implantable defibrillators reduce non-arrhythmic mortality? |
| Q36888495 | Cardiac arrest and hypertrophic cardiomyopathy. Role of the implantable defibrillator |
| Q77398563 | Cardiac death and stored electrograms in patients with third-generation implantable cardioverter-defibrillators |
| Q40568336 | Cardiology--II: Treatment of heart failure and atrial fibrillation and arrhythmias |
| Q74596984 | Causes and consequences of discontinuation of the implantable cardioverter-defibrillator therapy in non-terminally ill patients |
| Q35367477 | Circumstances and causes of out-of-hospital cardiac arrest in sudden death survivors |
| Q64961871 | Clinical Management for Survivors of Sudden Cardiac Death. |
| Q36465364 | Clinical review: beyond immediate survival from resuscitation-long-term outcome considerations after cardiac arrest |
| Q73670386 | Comparison of clinical characteristics and frequency of implantable defibrillator use between randomized patients in the Antiarrhythmics Vs Implantable Defibrillators (AVID) trial and nonrandomized registry patients |
| Q71724559 | Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. Worldwide Jewel Investigators |
| Q51084519 | Could implantable cardioverter defibrillators provide a human model supporting the learned helplessness theory of depression? |
| Q41342509 | Does reducing capacitance have potential for further miniaturisation of implantable defibrillators? |
| Q41120695 | Drugs or implantable cardioverter-defibrillators in patients with poor left ventricular function? |
| Q41630460 | Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest |
| Q31141947 | Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis |
| Q51566063 | Effects of waveform and polarity on defibrillation thresholds in humans using a transvenous lead system. |
| Q50969655 | Efficacy of the implantable cardioverter-defibrillator in the elderly. |
| Q77700074 | Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications |
| Q52890332 | Electrophysiologic Study versus Electrocardiographic Monitoring (ESVEM): a critical appraisal. |
| Q33789879 | Evaluating AVID, CASH, CIDS, CABG-patch and MADIT: are they concordant? |
| Q33150796 | Factors determining ICD implantation in drug therapy patients after termination of antiarrythmics versus implantable defibrillators trial |
| Q33174998 | High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular arrhythmias |
| Q72107677 | ICD therapy in survivors of sudden cardiac death awaiting heart transplantation |
| Q52132739 | Iatrogenic anxiety disorder related to failure of implantable defibrillator. |
| Q71566654 | Impact of the implantable defibrillator on mortality: the axiom of overall implantable cardioverter-defibrillator survival |
| Q44692922 | Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: is device implantation justified? |
| Q71566639 | Implantable cardioverter-defibrillator (ICD) indications in 1996: have they changed? |
| Q77739489 | Implantable cardioverter-defibrillator therapy: influence of left ventricular function on long-term results |
| Q78195236 | Implantable cardioverter-defibrillators |
| Q33777275 | Implantable devices versus antiarrhythmic drug therapy in recurrent ventricular tachycardia and ventricular fibrillation |
| Q40991178 | Implanted cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias |
| Q52894670 | Influence of patient characteristics in the selection of patients for defibrillator implantation (the AVID Registry). Antiarrhythmics Versus Implantable Defibrillators. |
| Q34027336 | Is primary antiarrhythmic drug therapy for ventricular arrhythmias obsolete? |
| Q33940866 | Large clinical trials in the management of ventricular arrhythmias. Applying group results to individual cases |
| Q40566016 | Limited predictive value of inducible sustained ventricular tachycardia for future occurrence of spontaneous ventricular tachycardia in patients with coronary artery disease and relatively preserved cardiac function |
| Q72306434 | Long-term outcomes and modes of death of patients treated with nonthoracotomy implantable defibrillators |
| Q33731644 | Management of ventricular arrhythmias: a trial-based approach |
| Q34085399 | Matching cardiac rhythm management technology to patient needs: pacing/ablation/implantable cardioverter defibrillators |
| Q45957265 | Mortality benefit of implantable cardioverter-defibrillator therapy in patients with persistent malignant ventricular arrhythmias despite amiodarone treatment. |
| Q33544331 | Navigation in the mega-trials waters: reflections on the Multicenter Automatic Defibrillator Implantation Trial and the Antiarrhythmics Versus Implantable Defibrillators Study |
| Q40991169 | Nonpharmacological therapy for malignant ventricular arrhythmias: implantable defibrillator trials |
| Q31884238 | Number needed to treat: caveat emptor |
| Q50101674 | Optimal Medications and Appropriate Implantable Cardioverter-defibrillator Shocks in Aborted Sudden Cardiac Death Due to Coronary Spasm |
| Q33175739 | Patients with structural heart disease, syncope of unknown etiology and inducible ventricular arrhythmias treated with implantable defibrillators |
| Q83782997 | Persistent left superior vena cava as a cause for an unsuccessful ICD implant |
| Q41465686 | Predictors of appropriate ICD therapy in patients with implantable cardioverter-defibrillator. |
| Q33175134 | Predictors of long-term survival in patients with malignant ventricular arrhythmias |
| Q41653923 | Primary prevention of sudden cardiac death in heart failure: will the solution be shocking? |
| Q52952690 | Prognosis of idiopathic dilated cardiomyopathy. |
| Q53624497 | Prospective trials of implantable cardioverter defibrillators versus drugs: are they addressing the right question? |
| Q36837604 | Recurrence of cardiac arrest after 14 years without ICD interventions: a VF cluster immediately after delivery. |
| Q36582211 | Risk stratification for sudden cardiac death in patients with non-ischemic dilated cardiomyopathy. |
| Q49791408 | Selection bias, interventions and outcomes for survivors of cardiac arrest |
| Q73236634 | Sudden Electrical Death |
| Q78164493 | Sudden cardiac death |
| Q45170638 | Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government |
| Q77947832 | Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation |
| Q33174912 | Sudden death in patients with implantable cardioverter-defibrillators |
| Q78540480 | Surgical coronary revascularization and antiarrhythmic therapy in survivors of out-of-hospital cardiac arrest |
| Q51797926 | T wave pacing inducing electrical storm and multiple shocks in an ICD-recipient: a novel complication of the automatic gain control function |
| Q52895969 | The AVID trial: evidence based or randomized control trials--is the AVID study too late? Antiarrhythmics Versus Implantable Defibrillators. |
| Q71964541 | The impact of implantable cardioverter-defibrillators on mortality among patients on the waiting list for heart transplantation |
| Q33544368 | The implantable cardioverter defibrillator as a "bridge to transplant": a viable clinical strategy? |
| Q33145454 | The implantable cardioverter-defibrillator. |
| Q40503530 | The management of ventricular arrhythmias in older patients after CAST. |
| Q73744527 | There should never be another antiarrhythmics versus implantable defibrillator (AVID) trial |
| Q41003450 | Use of the implantable defibrillator |
| Q39433699 | Ventricular fibrillation induced by high-output ICD shock: report of cases and review of literature |
| Q36842605 | Ventricular tachycardia initiated by high energy cardioversion in a patient with an implantable cardioverter defibrillator |
| Q42394705 | Who needs ventricular stimulation studies? |
| Q52897657 | Why the antiarrhythmics versus implantable defibrillator (AVID) trial sets the wrong precedent. |
| Q74603940 | [Current indications for implantable automatic defibrillators] |
| Q77339728 | [Implanted automatic defibrillator after ventricular fibrillation treated with semi-automatic defibrillation] |
| Q73656203 | [Practice guidelines of the Spanish Society of Cardiology on cardiac arrythmias] |
| Q28374292 | Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics V |
Search more.